Recent Price Movement and Market Context
The stock closed at ₹539.60 on 5 Feb 2026, down 1.26% from the previous close of ₹546.50. Intraday volatility saw prices fluctuate between ₹519.80 and ₹546.65. This places the stock significantly below its 52-week high of ₹732.00, while comfortably above its 52-week low of ₹386.15. Over the past week, Aster DM Healthcare has declined by 1.74%, contrasting with the Sensex’s 1.79% gain, highlighting relative underperformance in the short term.
Longer-term returns remain robust, with a 1-year gain of 13.84% compared to Sensex’s 6.66%, and an impressive 3-year return of 158.93% versus the benchmark’s 37.76%. Over five years, the stock has surged 252.45%, significantly outpacing the Sensex’s 65.60%. These figures underscore the company’s strong growth trajectory despite recent technical setbacks.
Technical Trend Analysis: Shift to Bearish Momentum
Technical trend assessments have shifted from mildly bearish to outright bearish, reflecting increased selling pressure. The Moving Average Convergence Divergence (MACD) indicator presents a bearish signal on the weekly chart, while the monthly MACD remains mildly bearish. This suggests that momentum is weakening in the near term, with potential for further downside if the weekly trend persists.
The Relative Strength Index (RSI) offers a neutral stance, showing no clear signal on either weekly or monthly timeframes. This indicates that the stock is neither overbought nor oversold, leaving room for directional movement based on other technical factors.
Moving Averages and Bollinger Bands
Daily moving averages reinforce the bearish outlook, with the stock trading below key averages, signalling downward momentum. The Bollinger Bands present a mixed picture: weekly bands are bearish, indicating price pressure near the lower band, while monthly bands show a mildly bullish stance, suggesting some longer-term support may be forming.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Additional Momentum Indicators: KST, Dow Theory, and OBV
The Know Sure Thing (KST) oscillator presents a divergence between weekly and monthly signals. The weekly KST is bearish, aligning with other short-term indicators, while the monthly KST remains bullish, hinting at potential longer-term strength. This divergence suggests that while short-term momentum is weakening, the broader trend may still hold some upside potential.
Dow Theory assessments are mildly bearish on both weekly and monthly charts, reinforcing the cautious stance. Meanwhile, On-Balance Volume (OBV) readings are mildly bearish across weekly and monthly timeframes, indicating that volume trends are not supporting a strong price rally and may be contributing to the downward pressure.
Mojo Score and Grade Update
MarketsMOJO has downgraded Aster DM Healthcare Ltd’s Mojo Grade from Sell to Strong Sell as of 4 Feb 2026, reflecting the deteriorating technical and fundamental outlook. The current Mojo Score stands at 23.0, signalling weak momentum and quality metrics. The Market Cap Grade remains low at 3, consistent with the company’s small-cap status and associated volatility.
These ratings underscore the need for investors to exercise caution, especially given the stock’s recent underperformance relative to the broader market and the bearish technical signals dominating the short-term charts.
Comparative Performance and Sector Context
Within the hospital sector, Aster DM Healthcare’s recent technical deterioration contrasts with some peers that have maintained steadier momentum. The sector itself has shown resilience, supported by ongoing demand for healthcare services, but the stock’s technical indicators suggest it is currently lagging behind.
Investors should weigh the company’s strong long-term returns against the current technical weakness, considering whether the recent price momentum shift represents a temporary correction or a more sustained downtrend.
Aster DM Healthcare Ltd or something better? Our SwitchER feature analyzes this small-cap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaway and Outlook
In summary, Aster DM Healthcare Ltd’s technical parameters reveal a clear shift towards bearish momentum in the short term, with weekly MACD, moving averages, and OBV all signalling increased selling pressure. The absence of RSI signals and mixed Bollinger Bands readings suggest that the stock is in a consolidation phase, but the prevailing trend is negative.
Long-term investors may find comfort in the company’s strong multi-year returns and the monthly bullish signals from KST and Bollinger Bands. However, the downgrade to a Strong Sell Mojo Grade and the deteriorating weekly technicals advise prudence. Investors should monitor key support levels near ₹520 and watch for any reversal signals before considering fresh exposure.
Given the current technical landscape, a cautious approach is warranted, with potential opportunities arising only if the stock demonstrates sustained improvement in momentum indicators and moving averages.
Summary of Key Technical Indicators:
- MACD: Weekly Bearish, Monthly Mildly Bearish
- RSI: No clear signal on weekly or monthly charts
- Bollinger Bands: Weekly Bearish, Monthly Mildly Bullish
- Moving Averages: Daily Bearish, price below key averages
- KST: Weekly Bearish, Monthly Bullish
- Dow Theory: Mildly Bearish on both weekly and monthly
- OBV: Mildly Bearish on weekly and monthly
Investors should continue to track these indicators closely as they provide critical insights into the stock’s price momentum and potential trend reversals.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
